Search

Search Constraints

You searched for: Author/Creator Inao, Mie

Search Results

2. A validation study of the Ursodeoxycholic Acid Response Score in Japanese patients with primary biliary cholangitis. (30th May 2020)

3. Chronic hepatitis caused by hepatitis C virus showing a discrepancy between serogroup and genotype because of intergenotypic 2b/1b recombination: A pitfall in antiviral therapy with direct‐acting antivirals. Issue 3 (25th September 2017)

4. Development of rare resistance‐associated variants that are extremely tolerant against NS5A inhibitors during daclatasvir/asunaprevir therapy by a two‐hit mechanism. Issue 12 (30th March 2016)

5. Furosemide as a factor to deteriorate therapeutic efficacy of rifaximin in patients with decompensated cirrhosis. Issue 11 (26th September 2020)

6. Furosemide as a factor to deteriorate therapeutic efficacy of tolvaptan in patients with decompensated cirrhosis. Issue 12 (21st September 2020)

7. Issue Cover. (22nd February 2022)

8. Machine learning in primary biliary cholangitis: A novel approach for risk stratification. (7th January 2022)

9. Multicenter prospective study to optimize the efficacy of triple therapy with telaprevir in patients with genotype 1b hepatitis C virus infection according to an algorithm based on the drug Adherence, IL‐28B Gene Allele and Viral Response Trial (AG & RGT). Issue 11 (3rd March 2015)